Why Did Penn Medicine Silence a Cancer-Free Womb? -By Fransiscus Nanga Roka

A Philadelphia Jury Answered A Question American Medicine Spent Four Years Avoiding: Who Allowed A Healthy Woman To Have Her Uterus Removed For A Cancer She Did Not Have? (November 2025) The answer is an indictment of a whole system. When Isis Spencer, a mother of three from Pennsylvania, lost her uterus and ovaries in 2021 at the Hospital of the University of Pennsylvania not because she had cancer but because two hospital networks, Main Line Health (MLH) and Penn Medicine just couldn’t be bothered to reconcile two conflicting lab results before wheeling her into an operating theatre.

The failure chain was almost laughably idiotic. DNA from another patient contaminated a biopsy at Lankenau Medical Center, creating an erroneous stage 2-3 endometrial cancer diagnosis. Normal T-cells but not myc, she says do everything a diligent patient would do over at Penn MedicineSpencer sought a second opinion from the right specialist: gynecologic oncologist Dr. Janos Tanyi, who quickly ran his own biopsy. The test was negative, her tissue showed no abnormalities. And then inexplicably, unforgivably, he did not tell her that his own lab had cleared her, he told her to go ahead with the hysterectomy anyway.

This is no accident, tragic or otherwise. A fucking governance failure disguised as clinical judgment. When final pathology on the excised uterus found, without a shadow of any doubt whatsoever, that there had NEVER been a cancer at all, this case became about professionalism in medicine, how our culture trusts data from abroad more than its own evidence and protects physician prerogative over patient autonomy.

In a jury’s $35 million verdict, there was brutal clarity on blame: Penn Medicine and Tanyi were found 35 percent responsible —$12.25 million for performing surgery on an incongruous, undisclosed result—while Main Line Health settled confidentially to tainting the sample in the first place. No amount of money can give Spencer back her uterus, undo the surgical menopause she had to have, or cure her migraines, nausea and psychological scars from this career by another name for an illness that was never real.

And if this flowing in one of America’s top academic medical systems, it will happen anyplace, Jakarta, Lagos or London anywhere obstetrician-gynecologists treat imported lab reports as unassailable truth and muteness toward patients as a good deedful act of care. Penn Medicine says it intends to appeal, maintaining that Tanyi simply relied on an outside lab. It is also exactly the indictment: lack of transparency means that blind trust in unverified data is not medicine — it is just malpractice in a white coat.

Strategic Recommendations for OB-GYN Physicians Worldwide

The Spencer verdict is not a cautionary tale about an errant doctor, it is a reflection of a system that allows irrevocable surgery to outdistance proven truth. If obstetrician-gynecologists everywhere is to spare themselves from the next bench of defending, then six disciplines need never again be non-obligatory.

There should never, ever, be a hysto-, oopho-, or mastectomy performed when internal and external pathology reports differ from one another. A discrepancy is not the sort of minor annoyance that can be whisked away with a scalpel-it’s a warning light requiring an independent third look at once before anyone touches the operating table.

Second, disclosure should not be optional and retrospective. When one’s own lab returns a result that contradicts the referring diagnosis, you must tell the patient, in full, before getting into consent mode. Efficient silence is not clinical judgment, but concealment.

Third, when an irreversible procedure is predicated on a cancer diagnosis, doctors should always require retesting of the tangible specimen rather than re-reading the same possibly cross-contaminated slide. Flawed evidence can provide a second opinion, but that means the second opinion is still flawed evidence.

Fourth, forensic standards themselves are a must be imposed on the laboratories. Chain-of-custody protocols should be, at least structurally, intrinsic safeguard to the scandals being reported here: One patient’s DNA can’t cross-contaminate another biopsy, that failure is what started this catastrophe.

The fifth change is informed consent, which needs to be a real conversation rather than forms. Surgeons must also be required to explicitly document disclosure of discordant results and that patients have been given real alternatives — including watchful waiting, repeat biopsy or delay — rather than being routed directly to the operating room as their only option.

Lastly, the profession must stop obscuring its failures via non-disclosure settlements. Public reporting of diagnostic-discordance cases should be required by all bodies such as FIGO, ACOG and national OB-GYN colleges, so that patterns of negligence emerge before they can spread into more unnecessary hysterectomies, more stolen fertility, more shattered trust.

A system’s arrogance measured in a womb: Isis Spencer Now is not the time for another quiet settlement; obstetrics and gynecology around the world need to respond with structural reform. Spencer’s uterus is gone. What the profession owes her and every patient after her, at the very least is the honesty that lay in hiding behind the desk of her doctors.

Fransiscus Nanga Roka

Faculty of Law University 17 August 1945 Surabaya and Managing Partner Law Firm Victorious Indonesia